Jennifer Humes
Net worth: 3 M $ as of 2026-05-30
Net worth: 3 M $ as of 2026-05-30
Jennifer Humes currently works at Roivant Sciences Ltd., as Chief Accounting Officer from 2025 and Roivant Sciences, Inc., as Chief Accounting Officer from 2025.
Ms. Humes also formerly worked at JPMorgan Chase & Co., as Controller-Global Investment Banking in 2024.
Ms. Humes received her undergraduate degree from the University of St. Thomas.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-19 | 113,364 ( 0.02% ) | 3 M $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| ROIVANT SCIENCES LTD. | Comptroller/Controller/Auditor | 2025-02-19 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Comptroller/Controller/Auditor | 2025-02-19 |
| Companies | Position | End |
|---|---|---|
| JPMORGAN CHASE & CO. | Corporate Officer/Principal | 2024-11-30 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 4 |
|---|---|
JPMorgan Chase & Co.
JPMorgan Chase & Co. Major BanksFinance Provides banking, asset management, investment banking, credit card and mortgage services | Finance |
Roivant Sciences Ltd.
Roivant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company through its subsidiaries develops restorative therapies for autoimmune diseases | Health Technology |
University of St. Thomas
University of St. Thomas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Health Technology |
Select your edition
All financial news and data tailored to specific country editions